INHIBIKASE

Swiss trademark · 797967 · Word mark · In force

Register entry

Registration number
797967
Application number
02996/2023
Status
In force
Type
Word mark
Filed
Mar 8, 2023
Registered
May 26, 2023
Published
May 26, 2023
Protected until
Mar 8, 2033
Priority
10.10.2022 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceutical preparations

As filed

Pharmazeutische Präparate.

Science, technology and IT

Pharmazeutische Forschung und Entwicklung; medizinische und wissenschaftliche Forschung und Entwicklung; wissenschaftliche Labordienstleistungen; wissenschaftliche und technologische Dienstleistungen und damit verbundene biologische Forschung und Entwicklung.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 9, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 09.10.2026

  2. May 26, 2023

    Registered

    Published in Swissreg on 26.05.2023

Parties

Holder

Inhibikase Therapeutics, Inc.

3350 Riverwood Parkway SE Suite 1900, Atlanta, Georgia 30339, US

Agent

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.